Considering Oncology Drug Value Assessment Moving Forward: FOCUS on value
Value frameworks, like healthcare in general, are very complicated, and the devil is in the details. How such frameworks assess therapies is meaningful to providers, patients, payers, and pharma companies. While drug companies seek to understand and evaluate the impact of value-based care to their products and pipelines, one of our senior scientists explores the ramifications to care delivery and its reimbursement.
View the article